CVE-2025-52653: Hcltech Dryice Myxalytics

Medium severity, CVSS 5.4. EPSS: 0.3% chance of exploitation in the next 30 days.

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

Affected products

• Hcltech Dryice Myxalytics: version 6.6 only

Published 2025-10-03. Last modified 2026-10-08.